Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria

Figure 2

Change of thyroglobulin (TG) levels under therapy (1 m = 1 month, 3 m = 3 months, 12 m = 12 months, and 24 m = 24 months).